Objectives: Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery and might be avoided with amiodarone prophylaxis. We investigated the long-term effect of prophylactic amiodarone, in patients undergoing isolated, elective coronary artery bypass grafting (CABG), as well as the long-term prognosis of patients with POAF. Methods: We retrospectively analysed patients included in the randomized, control trial RASCABG allocated to either placebo or amiodarone as POAF prophylaxis. Several outcomes were evaluated using national databases. Patients were stratified and compared by prophylactic groups and rhythm. Cox proportional hazard analysis was used for multivariable analysis. Kaplan-Meier survival curves were constructed to assess the probability of survival and cumulative incidence curves. Results: Prophylactic amiodarone was not related to long-term side effects in comparison to placebo. Patients who developed POAF, were more likely to develop late AF, and had a worse overall survival. There was no difference in the overall survival between prophylactic groups. In the competing risk analysis, amiodarone and POAF was not associated with an increased risk of readmission, but POAF was associated with an increased risk of late AF HR 2.28 [95% CI 1.15; 4.55]. In the multivariable analysis, amiodarone was not associated with late AF, readmission or long-term mortality. Further, no association was found between POAF and late AF, readmission or long-term mortality. Conclusion: Amiodarone is a safe drug for the prevention of POAF in the RASCABG-setting. POAF is related to long-term worse prognosis regarding late AF and mortality.
References
[1]
Raiten, J.M., Ghadimi, K., Augoustides, J.G., Ramakrishna, H., Patel, P.A., Weiss, S.J., et al. (2015) Atrial Fibrillation after Cardiac Surgery: Clinical Update on Mechanisms and Prophylactic Strategies. Journal of Cardiothoracic and Vascular Anesthesia, 29, 806-816. https://doi.org/10.1053/j.jvca.2015.01.001
[2]
Bessissow, A., Khan, J., Devereaux, P.J., Alvarez-Garcia, J. and Alonso-Coello, P. (2015) Postoperative Atrial Fibrillation in Non-Cardiac and Cardiac Surgery: An Overview. Journal of Thrombosis and Haemostasis, 13, 304-312. https://doi.org/10.1111/jth.12974
[3]
Greenberg, J.W., Lancaster, T.S., Schuessler, R.B. and Melby, S.J. (2017) Postoperative Atrial Fibrillation Following Cardiac Surgery: A Persistent Complication. European Journal of Cardio-Thoracic Surgery, 52, 665-672. https://doi.org/10.1093/ejcts/ezx039
[4]
Yadava, M., Hughey, A.B. and Crawford, T.C. (2016) Postoperative Atrial Fibrillation: Incidence, Mechanisms, and Clinical Correlates. Heart Failure Clinics, 12, 299-308. https://doi.org/10.1016/j.hfc.2015.08.023
[5]
Phan, K., Ha, H.S., Phan, S., Medi, C., Thomas, S.P. and Yan, T.D. (2015) New- Onset Atrial Fibrillation Following Coronary Bypass Surgery Predicts Long-Term Mortality: A Systematic Review and Meta-Analysis. European Journal of Cardio- Thoracic Surgery, 48, 817-824. https://doi.org/10.1093/ejcts/ezu551
[6]
Megens, M.R., Churilov, L. and Thijs, V. (2017) New-Onset Atrial Fibrillation after Coronary Artery Bypass Graft and Long-Term Risk of Stroke: A Meta-Analysis. Journal of the American Heart Association, 6, e007558. https://doi.org/10.1161/JAHA.117.007558
[7]
Tulla, H., Hippelainen, M., Turpeinen, A., Pitkanen, O. and Hartikainen, J. (2015) New-Onset Atrial Fibrillation at Discharge in Patients after Coronary Artery Bypass Surgery: Short- and Long-Term Morbidity and Mortality. European Journal of Cardio-Thoracic Surgery, 48, 747-752. https://doi.org/10.1093/ejcts/ezu526
[8]
Alawami, M., Chatfield, A., Ghashi, R. and Walker, L. (2018) Atrial Fibrillation after Cardiac Surgery: Prevention and Management: The Australasian Experience. Journal of the Saudi Heart Association, 30, 40-46. https://doi.org/10.1016/j.jsha.2017.03.008
[9]
Thein, P.M., White, K., Banker, K., Lunny, C., Mirzaee, S. and Nasis, A. (2018) Preoperative Use of Oral Beta-Adrenergic Blocking Agents and the Incidence of New-Onset Atrial Fibrillation after Cardiac Surgery. A Systematic Review and Meta-Analysis. Heart, Lung and Circulation, 27, 310-321. https://doi.org/10.1016/j.hlc.2017.08.026
[10]
Lomivorotov, V.V., Efremov, S.M., Pokushalov, E.A. and Karaskov, A.M. (2016) New-Onset Atrial Fibrillation after Cardiac Surgery: Pathophysiology, Prophylaxis, and Treatment. Journal of Cardiothoracic and Vascular Anesthesia, 30, 200-216. https://doi.org/10.1053/j.jvca.2015.08.003
[11]
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., et al. (2016) ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. European Journal of Cardio-Thoracic Surgery, 50, 2893-2962. https://doi.org/10.1093/ejcts/ezw313
[12]
Zebis, L.R., Christensen, T.D., Thomsen, H.F., Mikkelsen, M.M., Folkersen, L., Sorensen, H.T., et al. (2007) Practical Regimen for Amiodarone Use in Preventing Postoperative Atrial Fibrillation. The Annals of Thoracic Surgery, 83, 1326-1331. https://doi.org/10.1016/j.athoracsur.2006.09.096
[13]
Schmidt, M., Maeng, M., Jakobsen, C.J., Madsen, M., Thuesen, L., Nielsen, P.H., et al. (2010) Existing Data Sources for Clinical Epidemiology: The Western Denmark Heart Registry. Clinical Epidemiology, 2, 137-144. https://doi.org/10.2147/CLEP.S10190
[14]
Lynge, E., Sandegaard, J.L. and Rebolj, M. (2011) The Danish National Patient Register. Scandinavian Journal of Public Health, 39, 30-33. https://doi.org/10.1177/1403494811401482
[15]
Helweg-Larsen, K. (2011) The Danish Register of Causes of Death. Scandinavian Journal of Public Health, 39, 26-29. https://doi.org/10.1177/1403494811399958
[16]
Fine, J. and Gray, R. (1999) A Proportional Hazards Model for the Subdistribution of a Competing Risk. Journal of the American Statistical Association, 94, 496-509. https://doi.org/10.1080/01621459.1999.10474144
[17]
Teerakanok, J., Tantrachoti, P., Chariyawong, P. and Nugent, K. (2016) Acute Amiodarone Pulmonary Toxicity after Surgical Procedures. The American Journal of the Medical Sciences, 352, 646-651. https://doi.org/10.1016/j.amjms.2016.08.013
[18]
Jackevicius, C.A., Tom, A., Essebag, V., Eisenberg, M.J., Rahme, E., Tu, J.V., et al. (2011) Population-Level Incidence and Risk Factors for Pulmonary Toxicity Associated with Amiodarone. American Journal of Cardiology, 108, 705-710. https://doi.org/10.1016/j.amjcard.2011.04.024
[19]
Trohman, R.G., Sharma, P.S., McAninch, E.A. and Bianco, A.C. (2018) Amiodarone and the Thyroid Physiology, Pathophysiology, Diagnosis and Management. Trends in Cardiovascular Medicine, 29, 285-295. https://doi.org/10.1016/j.tcm.2018.09.005
[20]
Hashmi, A., Keswani, N.R., Kim, S. and Graham, D.Y. (2016) Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone. The Southern Medical Journal, 109, 83-86. https://doi.org/10.14423/SMJ.0000000000000413
[21]
Maoz, K.B., Dvash, S., Brenner, S. and Brenner, S. (2009) Amio-darone-Induced Skin Pigmentation and Multiple Basal-Cell Carcinomas. International Journal of Dermatology, 48, 1398-1400. https://doi.org/10.1111/j.1365-4632.2008.03819.x
[22]
Lee, S.H., Kang, D.R., Uhm, J.S., Shim, J., Sung, J.H., Kim, J.Y., et al. (2014) New- Onset Atrial Fibrillation Predicts Long-Term Newly Developed Atrial Fibrillation after Coronary Artery Bypass Graft. American Heart Journal, 167, 593-600. https://doi.org/10.1016/j.ahj.2013.12.010
[23]
Lowres, N., Mulcahy, G., Jin, K., Gallagher, R., Neubeck, L. and Freedman, B. (2018) Incidence of Postoperative Atrial Fibrillation Recurrence in Patients Discharged in Sinus Rhythm after Cardiac Surgery: A Systematic Review and Meta-Analysis. Interactive CardioVascular and Thoracic Surgery, 26, 504-511. https://doi.org/10.1093/icvts/ivx348
[24]
Pillarisetti, J., Patel, A., Bommana, S., Guda, R., Falbe, J., Zorn, G.T., et al. (2014) Atrial Fibrillation Following Open Heart Surgery: Long-Term Incidence and Prognosis. Journal of Interventional Cardiac Electrophysiology, 39, 69-75. https://doi.org/10.1007/s10840-013-9830-6
